Dolton, M. J., & McLachlan, A. J. (2013). Reply to “What Types of Candida Infections Should Be Included When Evaluating Breakthrough Infections during Posaconazole Prophylaxis?”. American Society for Microbiology.
Stile di citazione ChicagoDolton, Michael J., e Andrew J. McLachlan. Reply to “What Types of Candida Infections Should Be Included When Evaluating Breakthrough Infections During Posaconazole Prophylaxis?”. American Society for Microbiology, 2013.
Citazione MLADolton, Michael J., e Andrew J. McLachlan. Reply to “What Types of Candida Infections Should Be Included When Evaluating Breakthrough Infections During Posaconazole Prophylaxis?”. American Society for Microbiology, 2013.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.